Remarkably, in all three patients, NR4A3 expression levels were relatively higher after the ATRA leukemia cell differentiation treatments (Fig. 4B), whereas the expression levels of NR4A1 were not consistently or overtly altered. The gene discussed is NR4A1; the disease is leukemia.